- Home
- RGT vs ANIX Comparison
RGT vs ANIX Comparison
Compare RGT & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGT | ANIX |
|---|---|---|
| Founded | 1986 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.0M | 104.0M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | RGT | ANIX |
|---|---|---|
| Price | $14.25 | $3.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.67 |
| AVG Volume (30 Days) | 18.1K | ★ 107.8K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | N/A | ★ 12.82 |
| EPS | ★ 0.92 | N/A |
| Revenue | N/A | ★ $210,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.45 | $2.44 |
| 52 Week High | $14.99 | $5.46 |
Technical Indicators
Market Signals| Indicator | RGT | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 57.46 |
| Support Level | $13.94 | $2.99 |
| Resistance Level | $14.95 | $3.10 |
| Average True Range (ATR) | 0.24 | 0.16 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 34.57 | 76.38 |
Price Performance
Historical ComparisonAbout RGT Royce Global Value Trust Inc.
Royce Global Value Trust Inc is a diversified closed-end investment company. The fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples, and energy. Geographically, it has presence in the region of the United Kingdom, Japan, the United States, Canada, France, Hong Kong, and Germany.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.